Status:

COMPLETED

Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes Diet Treated

Lead Sponsor:

University of Messina

Conditions:

Gestational Diabetes

Eligibility:

FEMALE

18-44 years

Phase:

NA

Brief Summary

The aim of this study is to verify the beneficial effects on insulin resistance and fetal sonographic parameters of a diet supplementation of myoinositol taken during the third trimester by pregnant w...

Detailed Description

Background and Aim: Gestational diabetes mellitus (GDM) is a carbohydrate intolerance diagnosed during pregnancy that is not clearly an overt diabetes. It is characterized by an increase of the physi...

Eligibility Criteria

Inclusion

  • Singleton pregnancy affected by gestational diabetes

Exclusion

  • Multiple pregnancy and known or suspected fetal malformations

Key Trial Info

Start Date :

November 14 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2020

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03763669

Start Date

November 14 2018

End Date

March 15 2020

Last Update

March 24 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Obstetrics & Gynecology - Policlinico "G. Martino"

Messina, Italy, 98125

Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes Diet Treated | DecenTrialz